Esra Zeynelgil

10PUBLICATIONS
38CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Sep 24, 2026
Emergency Surgery Independently Predicts Postoperative Recurrence in Patients with Pathologic T3N0M0 Colon Cancer: A Retrospective Single-Center Cohort Study.

|Sep 15, 2026
Long-Term Outcomes and Prognostic Factors in Metastatic ALK-Rearranged Non-Small Cell Lung Cancer Treated with ALK Tyrosine Kinase Inhibitors: Real-World Evidence from a High-Volume Thoracic Diseases Center.

|Apr 14, 2026
Impact of Prior mRNA COVID-19 Vaccination on PFS2 in NSCLC Patients Receiving Second-Line Immune Checkpoint Inhibitors: A Real-World Analysis.

Selahattin Çelik, Engin Eren Kavak, Esra Zeynelgil

|Jan 27, 2026
Prognostic Significance of Lung Immune Prognostic Index at Diagnosis in Stage III Non-Small Cell Lung Cancer.

Tülay Eren, Engin Eren Kavak, İsmail Dili

|Jan 10, 2026
Prognostic Value of STAS, Lymph Node Metastasis, and VPI in NSCLC ≤ 4 cm Treated with Lobectomy.

Esra Zeynelgil, Abdülkadir Koçanoğlu, Ata Türker Arıkök

|Dec 16, 2025
BMI and PNI as predictors of treatment completion and survival in locally advanced HNSCC receiving sequential chemoradiotherapy.

Esra Zeynelgil, Engin Eren Kavak, İsmail Dilli

Pageof 2

Frequent Collaborators

4 joint publications

Engin Eren Kavak

3 joint publications

Tulay Eren

3 joint publications

Serdar Karakaya

3 joint publications

Abdülkadir Koçanoğlu